“…The mESC were maintained in an undifferentiated state on a feeder layer of irradiated mouse fibroblasts with maintenance medium containing Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) supplemented with 15% FBS (Hyclone, Logan, UT), 0.1 mM 2‐mercaptoethanol (Sigma, St. Louis, MO, USA), 0.1 mN non‐essential amino acids (Invitrogen), 1% penicillin/streptomycin (Invitrogen), 2 mM L‐glutamine (Invitrogen), and 1000 U/mL mouse leukemia inhibitory factor (LIF, ESGRO; Chemicon, Temecula, CA, USA) at 37°C as described previously (12). Three stable lines of mESC were employed: 1) the TL‐1 mESC line derived from 129sv/J mice (courtesy of Dr. Thomas Quertermous, Stanford University, Stanford, CA), 2) luciferase‐transfected mESC (mESC‐luc+, courtesy of Dr. Joseph C. Wu, Stanford University, Stanford, CA), and 3) Nkx2.5 (cardiomyocyte differentiation specific promoter)‐green fluorescent protein (GFP) transfected mESC (mESC‐Nkx2.5‐GFP + , courtesy of Dr. Takayuki Morisaki, National Cardiovascular Center Research Institute, Osaka, Japan) were used.…”